Product Description
Overall, the global port needle market was valued at $153 million in 2023. This is expected to increase over the forecast period at a CAGR of 1.4% to reach $170 million.
Throughout this medical market research, we analyzed over 12 port needle companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for port needles includes conventional and safety port needles.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Port Needle Market Insights
Power-injectable implantable ports are specially crafted to endure elevated pressures, mainly for administering contrast dye during computed tomography scans. This has led to a notable increase in the market for premium-priced port needles specifically designed to handle the high-pressure demands of power-injections.
Global Port Needle Market Share Insights
- In 2023, Becton Dickinson (BD) led the port needle market with a broad portfolio inherited from Bard that includes Bard® Winged, EZ Huber®, SafeStep®, and HuberPlus®. BD‘s strong presence in the implantable port market ensures its continued dominance.
- In 2023, ICU Medical ranked second, driven by its popular GRIPPER PLUS® safety port needle, available in non-power-injectable and GRIPPER PLUS® POWER P.A.C. versions. The product range also comprises GRIPPER® Needles and the GRIPPER® Micro Blunt Cannula Non-Coring Safety Needle, known for its small infusion site.
- In 2023, B. Braun secured the third position with the WHIN® device, offering protection against needlestick injuries and fluid exposure. This device comes in three configurations, with or without a Y-site, but all B. Braun port needles are non-power-injectable.
Market Segmentation Summary
- Conventional Port Needle Market
- Safety Port Needle Market
Global Research Scope Summary
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2023 |
Forecast | 2024-2030 |
Historical Data | 2020-2023 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.